Sawsan Mohammed Jabbar AL-Hasnawi, Salman Aziz Adoos
الملخص الانجليزي
Objective: the aim of the study is to determine the prevalence of LADA among group of clinically
diagnosed type 2 diabetes mellitus.
Methodology: sample size equal to 280 patients with type 2 D.M. were subjected in this study,
participating patients were consecutively recruited from Diabetes outpatient clinic in AL-Hussein
Teaching Hospital in Karbala from June, 2013 through January, 2014. A clinical questioner containing
personal data, family history, type of diabetes, type of treatment, FBS, HA1C, BMI, diabetes duration&
complications of diabetes. For analysis of data Prevalence of LADA among D.M.2 cases was
calculated as the proportion of LADA cases in the D.M.2 cases. The Chi square test (X2) was used to
assess the significance (P-value) of differences in frequencies of categorical variables.
Results: prevalence of LADA among D.M.2 patients was 12.1%. A significant difference in family
history, BMI, FBS, HA1C and duration of D.M was found between the studied groups.
Conclusion: The prevalence of LADA is clinically underestimated among D.M2 patients
and age of onset of diabetes should no longer be considered as a valid way to differentiate
diabetes.
Recommendation: the study recommends screening for islet cell autoantibodies as GAD65 for all
patients with diabetes at onset or beginning of disease.
سوسن محمد جبار الحسناوي | Sawsan M. Jabbar AL-Hasnawi | 3233